30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Bioventus Launches DUROLANE in Malaysia -

Bioventus launched DUROLANE® single-injection joint fluid osteoarthritis therapy in Malaysia, through exclusive distribution partner Athrotech. The company cited estimates of 20% of the adult Malaysian population has OA, noting that knee OA is the most common form. Further, the market exhibits a favorable mix of private, payor and self-pay patients. This is the fourth market in Asia that Bioventus has entered with DUROLANE. (Bioventus, 1/29/19)